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INTRODUCTION:Upper urinary tract occlusion iswell recognized in patientswith chronic ketamine abuse.
The mechanism is generally unknown, but the ulcerative cystitis contracture may be responsible for
obstruction.Wepresent theﬁrst reporteduse of theResonancemetallic ureteric stent in themanagement
ureteric obstruction caused by ketamine-induced uropathy.
PRESENTATION OF CASE: A 31-year-old lady with one-year history of recreational ketamine abuse pre-
sented with symptoms related to drug-induced ulcerative cystitis over twelve-months. She presented
with acute renal failure with bilateral pyonephrosis and sepsis, and was initially treated with bilateral
nephrostomy insertions and antegrade stenting. The J stents recovered the renal function, but the patient
suffered from recurrent urinary tract infections (UTI’s) with the prosthesis in-situ. The patient success-
fully underwent bilateral insertion of 12 cm 6.0 French Cook Resonancemetallic ureteric stents. One year
following the placement of the metallic stents, the patient maintained optimal renal function with no
episode of UTI.
DISCUSSION: Ketamine induced uropathy is a well documented complication of chronic drug-induced
ulcerative cystitis. Themechanical strength and inert property of metallic ureteric stentsmake it an ideal
device to manage this problematic benign cause of ureteric obstruction.
CONCLUSION: This is the ﬁrst reported case of therapeutic bilateral metallic ureteric stents in the man-
agement of patients with ketamine induced uropathy with one year follow up.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Ketamine, an anaesthetic agent introduced in 1960’s has cur-
rently become a common recreational drug. Street ketamine
abuse is associated with a serious urological condition termed as
ketamine associated ulcerative cystitis, in which patients typically
presentwith severe lowerurinary tract symptomswithdysuria and
haematuria [1].
The involvement of upper urinary tract is often observed in
ketamine induced uropathy (KIU) [2,3]. The incidence of KIU with
accompanying upper tract obstruction ranging from 13–51% [2–4].
The severity of the obstruction is dose dependent on the abuser
Fig. 1.
The management of the upper tract KIU is necessary in the
presence of worsening renal function or pyonephrosis. Retro-
grade pyelogram following cystoscopy may be impossible due to
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bladder contracture. Therefore, the insertion of nephrostomy tube
followed by antegrade ureteric stenting may be the only suitable
treatment option for patient.
The efﬁcacy of chronic indwelling ureteric stents in patients
with KIU is not well documented in medical literature. The
common complications of the utilization of double J stents in
patient benign and malignant ureteric obstruction include pain,
haematuria, infection and failure of the stent due to worsening
obstruction.
In this case report we evaluate effectiveness of treating patient
with KIU using metallic ureteric stent with one year follow up.1
2. Presentation of case
A 31-year-old lady, who is known to have regular contact with
recreational ketamine presented with severe lower urinary tract
1 KIU: ketamine induced uropathy.
http://dx.doi.org/10.1016/j.ijscr.2015.01.008
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. CT scan shows bilateral hydronephrosis associated with pyonephrosis (black arrows).
symptoms and haematuria. Her initial ultrasound of the urinary
tract and renal function was normal.
One year following her initial presentation, the patient began to
get intermittent urinary tract infections. CT scan revealed bilateral
mild to moderate hydronephrosis. There was deterioration in her
renal function as well.
The patient then presented with sepsis and acute kidney injury.
She had developed pyonephrosis, which was treated with bilat-
eral nephrostomy drainage. Following the initial acute phase, the
patient underwent bilateral antegrade JJ stenting to manage the
chronic bilateral KIU.
The patient experienced intermittent pain and severe haema-
turia and anemia for which she required a transfusion. One month
following theureteric stent inplacement, her renal function contin-
ued to deteriorate and she presented with urosepsis. In view of the
presence of persistent, unresolved infection and obstruction, the
polymer ureteric stent was removed and nephrostomy drainage
tubes were left in situ.
At this point, further management options considered included
the insertion of larger caliber polymer ureteric stents or metallic
stents.
In view of shorter term efﬁcacy of polymer stent, bilateral
antegrade insertion of 12 cm (6.0 French) Cook Resonance metal-
lic ureteric stent was performed under local anaesthetic. The
patientmade an uneventful recovery andwas followed up on three
monthly basis with urine culture and renal function tests.
Twelve months following the Resonance stent, the patient had
stable renal function withminimal haematuria. One episode of UTI
was detected one month following the treatment. No further posi-
tive bacterial growthwere detected onurine culture on subsequent
visits
3. Discussion
KIU has become more prevalent in recent years and will con-
tinue to be challenging for clinicians to deal with its chronic
complications. The detection of hydronephrosis in patients with
KIU is apparent in nearly half of the patients [5] and may indicate
early obstruction that can subsequently lead to irreversible renal
impairment with concomitant infection.
The accepted treatment options of chronic ureteric obstruc-
tion is polymer double J stent that has been introduced since
1970s. Although the efﬁcacy of such treatment modality is well
documented, the related complications such as stent migration
encrustation, haematuria, UTI, blockage and stent failure due to
extrinsic compression are equally well known [6].
The other disadvantage of chronic polymer stenting is the need
for periodic stent changes, incurring costs and operative risks.
The Resonance metallic stent is a tightly coiled nickel cobalt
chromiummolybdenumalloy. This prosthesis has different charac-
teristics compared to the early generation self-expandable devices
primary used for malignant obstruction [7–8]. The advantages
of Resonance stent include enhanced tensile strength and longer
dwell time [9]. Five year experience of the utilization of suchmetal-
lic stent for chronic obstruction also demonstrated no signiﬁcant
problem with encrustation, haematuria or infection [10].
In this case study, we present a one year outcome of Resonance
stent in themanagementofKIUwithmaintenanceof renal function,
resolution of recurrent urinary tract infection and haematuria in a
patient who did not tolerate polymer JJ stent.
4. Conclusion
To our knowledge, this is the ﬁrst case of therapeutic metallic
ureteric stent insertion in the treatment of KIU with favorable one
year follow up.
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